A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

Yusuf Yazici,1 Lin Xie,2 Adesuwa Ogbomo,2 Lorie A Ellis,3 Kavitha Goyal,4 Amanda Teeple,5 Ece A Mutlu,6 Ismail Simsek7 1Department of Internal Medicine, Division of Rheumatology, New York University Hospital for Joint Diseases, New York, NY, USA; 2STATinMED Research, Health Economics and Outcomes Re...

Full description

Saved in:
Bibliographic Details
Main Authors: Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
Discontinuation
switch
inflammatory bowel disease
rheumatoid arthritis
Medicine (General)
R5-920
Online Access:https://doaj.org/article/a46f2b294146462c85a0c81712b86f9f
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items